Search Site
Related Products
AMG837GPR40 agonist,orally bioavailable

AMG837

Catalog No. B5834
Size Price Stock
10mg Please Inquire Please Inquire
50mg Please Inquire Please Inquire

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

AMG837

AMG837 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

AMG837 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Chemical Properties

Cas No. 865231-46-5 SDF Download SDF
Chemical Name (S)-3-(4-((4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid
Canonical SMILES CC#C[C@@](C1=CC=C(OCC2=CC(C3=CC=C(C(F)(F)F)C=C3)=CC=C2)C=C1)([H])CC(O)=O
Formula C26H21F3O3 M.Wt 438.44
Solubility Soluble in DMSO Storage Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request

Background

AMG 837 is a potent and orally bioavailable GPR40 agonist (EC50=14nM). [1]

GPR40 is a G protein-coupled receptor that is activated by free fatty acid. It is located on the cell surface of pancreatic beta-cells, gastrointestinal enteroendocrine cells and immune cells etc. GPR40 is reported to be related the stimulation effects of fatty acids on insulin and incretin secretion. [2]

AMG 837 treatment on GPR40 containing cell membrane increases [35S]-GTPγ binding (EC=1.5±0.1 nM). AMG 837 also stimulates Ca2+ influx (EC50 = 13.5±0.8 nM) in CHO cells transfected with GPR40 and aequorin. [2]

The insulin secretion is stimulated and the postprandial glucose level is lowered in 8-week old Sprague-Dawley rats orally treated with AMG 837. In Zucker fatty rats treated with AMG 837 daily for 21-days shows decreased glucose excursions and elevated glucose stimulated insulin secretion in glucose tolerance tests. [2]

References:
1.  Houze JB, Zhu L, Sun Y et al. AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1267-70.
2.  Lin DC, Zhang J, Zhuang R et al. AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents. PLoS One. 2011;6(11):e27270.